What is "catumaxomab"

n. A rat-murine hybrid monoclonal antibody used to treat certain cancers.

Catumaxomab (trade name Removab) is a rat- mouse hybrid monoclonal antibody which is used to treat malignant ascites, a condition occurring in patients with metastasizing cancer. It binds to antigens CD3 and EpCAM. It is in clinical trials in the United States currently and is used in Europe. It was developed by Fresenius Biotech and Trion Pharma ( Germany).